Waterlogged brain region helps scientists gauge damage caused by Parkinson's disease

July 26, 2017
NIH-funded scientists have discovered that Parkinson's disease increases the amount of "free" water in a particular brain area. Credit: David Vaillancourt, Ph.D., University of Florida.

Scientists at the University of Florida have discovered a new method of observing the brain changes caused by Parkinson's disease, which destroys neurons important for movement. The development suggests that fluid changes in a specific brain area could provide a way to track that damage. The study, published in the journal Brain, was supported by the NIH's National Institute of Neurological Disorders and Stroke (NINDS).

"By finding a new way to detect and track how Parkinson's affects the brain, this study provides an important tool for assessing whether a drug might slow or stop those changes and keep symptoms from getting worse," said NINDS Program Director Daofen Chen, Ph.D.

The researchers, led by David Vaillancourt, Ph.D., a professor of applied physiology and kinesiology at the University of Florida in Gainesville, FL, used a form of MRI that differentiates between contained in brain cells and "free" water outside of cells. Their analysis focused on the substantia nigra, a brain structure where Parkinson's disease kills neurons that use the chemical dopamine to communicate with other cells. The results showed that the amount of free water in that brain area stayed the same over the course of a year in healthy individuals but increased in early-stage Parkinson's patients during that period and increased further over the next three years. This confirms and expands on a prior study by the same group that measured free water over just one year. The new findings also revealed the increase in free water was linked to worsening symptoms.

"The amount of free water doesn't just change over one year - it keeps progressively increasing, which suggests that it's tracking the progressive degeneration of neurons," said Dr. Vaillancourt.

The researchers used a scale to evaluate patient's movement problems, with Stage One on the scale being the least severe and Stage Five being the most advanced. Patients who moved up a stage on the scale during the four years of the study had a greater free water increase than patients who remained at the same stage, suggesting the change reflected Parkinson's-related damage to neurons.

Parkinson's disease destroys dopamine-producing cells in the substantia nigra, which connect to adjacent brain areas. Dr. Vaillancourt's study showed that a greater free water increase in the was associated with a decrease in dopamine neuron activity in one of these nearby regions, supporting the idea that free water changes are related to progression of the disease.

"That correlation is encouraging because it pins down the biological relevance of free water," Dr. Vaillancourt said.

The study's results suggest that the MRI-based free water measurement could be used in Parkinson's disease . If a treatment slows or stops the increase in free water, it might be evidence that the drug is slowing the progressive loss of dopamine neurons.

The researchers used data from the Parkinson's Progression Markers Initiative (PPMI), a large study sponsored by the Michael J. Fox Foundation that has been collecting information on recently diagnosed Parkinson's patients from over 30 different U.S. and international sites. The fact that Dr. Vaillancourt's team found similar patterns in patients at every location boosted his confidence in the results because, like the PPMI, clinical trials must collect data from many sites using numerous different MRI machines.

"The PPMI data is real-world messy data, and when you find the effect in real-world messy data, it makes you think that it has legs," he said.

Dr. Vaillancourt speculated that his team's free water approach could make clinical trials less expensive by reducing the number of participants they would need to enroll. His team is currently running just such a study using free water to gauge the effect of a potential Parkinson's treatment. At the same time, the group is attempting to develop computer programs that will make free water analysis faster and easier. Future studies are needed to track changes in free water over longer time spans and in other regions and to determine what causes them.

Explore further: Breakthrough measures Parkinson's progression in the brain

More information: Burciu et al. Progression marker of Parkinson's disease: a 4-year multi-site imaging study, Brain (2017). DOI: 10.1093/brain/awx146

Related Stories

Breakthrough measures Parkinson's progression in the brain

May 26, 2015
University of Florida researchers have identified a biomarker that shows the progression of Parkinson's disease in the brain, opening the door to better diagnosis and treatment of the degenerative disease.

Scientific discovery may change treatment of Parkinson's disease

March 22, 2017
When monitoring Parkinson's disease, SPECT imaging of the brain is used for acquiring information on the dopamine activity. A new study conducted in Turku, Finland, shows that the dopamine activity observed in SPECT imaging ...

Biomarker breakthrough could improve Parkinson's treatment

August 15, 2016
A new, non-invasive way to track the progression of Parkinson's disease could help evaluate experimental treatments to slow or stop the disease's progression.

Conversion of brain cells offers hope for Parkinson's patients

April 11, 2017
Researchers at Karolinska Institutet have made significant progress in the search for new treatments for Parkinson's disease. By manipulating the gene expression of non-neuronal cells in the brain, they were able to produce ...

'Red hair' gene variant may underlie association between melanoma and Parkinson's disease

March 2, 2017
A gene variant that produces red hair and fair skin in humans and in mice, which increases the risk of the dangerous skin cancer melanoma, may also contribute to the known association between melanoma and Parkinson's disease. ...

Recommended for you

Singing may be good medicine for Parkinson's patients

August 11, 2017
(HealthDay)—Singing? To benefit people with Parkinson's disease? It just may help, a researcher says.

Tracing the path of Parkinson's disease proteins

August 4, 2017
As neurodegenerative disorders such as Parkinson's and Alzheimer's disease progress, misfolded proteins clump together in neurons, recruiting normal proteins in the cell to also misfold and aggregate. Cells in which this ...

Diabetes drug shows potential as disease-modifying therapy for Parkinson's disease

August 3, 2017
A drug commonly used to treat diabetes may have disease-modifying potential to treat Parkinson's disease, a new UCL-led study suggests, paving the way for further research to define its efficacy and safety.

Two new studies offer insights into gastrointestinal dysfunction in Parkinson's patients

July 31, 2017
Constipation is one of the most common non-motor related complaints affecting Parkinson's disease (PD) patients. Two important studies from the same research group published in the Journal of Parkinson's Disease expand the ...

New drug may treat and limit progression of Parkinson's disease

July 31, 2017
Researchers at Binghamton University have developed a new drug that may limit the progression of Parkinson's disease while providing better symptom relief to potentially hundreds of thousands of people with the disease.

A new insight into Parkinson's disease protein

July 28, 2017
Abnormal clumps of certain proteins in the brain are a prominent feature of Parkinson's and other neurodegenerative diseases, but the role those same proteins might play in the normal brain has been unknown.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.